Omeprazolo Sun Pharma Italia Srl (Omeprazole)

Omeprazole, the active ingredient in Omeprazolo Sun Pharma Italia Srl, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazolo Sun Pharma Italia Srl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on gastric acid secretion pathways. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal erosion. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition.

Adverse reactions to omeprazole vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: transient and often mild. - Abdominal pain: occasional discomfort. - Flatulence: mild bloating. - Constipation: infrequent but reported.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may occur with prolonged use. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia. - Bone fractures: associated with long‑term therapy. - Liver enzyme elevation: indicates possible hepatic stress. - Stevens‑Johnson syndrome: rare but serious skin reaction.

When using Omeprazolo, consider the following safety measures: - Assess renal function: adjust use in patients with severe impairment. - Evaluate hepatic function: use cautiously in liver disease. - Review long‑term use: monitor for nutrient malabsorption and bone health. - Pregnancy and lactation: weigh benefits against potential risks. - Concomitant medications: check for interactions that may affect drug levels. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Omeprazole may affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased antiviral efficacy due to reduced gastric acidity. - Methotrexate (high dose): increased systemic exposure, risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Digoxin: possible increase in serum concentrations. - Phenytoin: may reduce plasma levels, affecting seizure control.